For over 30 years, RIGHT has been funding innovative cutting edge research
RIGHT's research initiated the development of immunologic technologies applicable to both clinical trials and diagnostics
RIGHT has partnered with its commercial spin offs to transfer the discoveries of RIGHT's research to patient therapies
The Coronavirus pandemic (COVID-19) is in everyone's mind and heart. We are supporting a project to quickly identify improved drug combinations for COVID-19, with the goal of supplying safer and more robust treatment to a larger fraction of patients.